The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial by Dalal HM, Taylor RS, Jolly K, et al. European Journal of Preventive Cardiology, 26(3) pp. 262–272, DOI: 10.1177/2047487318806358
In Table 3 of the above article the values in the 4 months column were printed incorrectly. The correct version of this table is below:
Table 3.
Secondary objective outcomes at baseline and follow up. Data are mean (standard deviation (SD), n) unless otherwise indicated.
| Outcome |
Baseline |
Follow up |
||||||
|---|---|---|---|---|---|---|---|---|
|
4 months |
12 months |
|||||||
| REACH-HF | Control | REACH-HF | Control | REACH-HF | Control | Between-group difference | p value | |
| ISWT (meters) | 262.3 (153.4, 99) | 239.7 (152.4, 103) | 319.2 (174.5, 85) | 282.8 (166.8, 85) | 328.5 (181.3, 66) | 294.3 (215.5, 75) | 0.1 (–33.3 to 33.5) | 0.995 |
| Number of days/week with at least 10 minutes/day activity >100 milli-g* | 5.8 (2.3, 99) | 5.9 (1.9, 103) | 5.5 (2.4, 88) | 5.8 (2.1,93) | 5.6 (2.4, 78) | 5.5 (2.6, 84) | 0.2 (–0.4 to 0.7) | 0.601 |
| Average time/day (minutes) | ||||||||
| ≤20 milli-g* | 1104 (102, 99) | 1106 (114, 103) | 1107 (110, 88) | 1092 (116, 93) | 1092 (124, 78) | 1103 (118, 84) | –7 (–29 to 15) | 0.534 |
| 21–40 milli-g* | 141 (35, 99) | 136 (35, 103) | 140 (35, 88) | 138 (30, 93) | 142 (39, 78) | 138 (34, 84) | –1 (–9 to 8) | 0.880 |
| 41–60 milli-g* | 80 (25, 99) | 80 (27, 103) | 80 (27, 88) | 82 (26, 93) | 81 (30, 78) | 81 (28, 84) | 0 (–6 to 6) | 0.901 |
| 61–80 milli-g* | 45 (21, 99) | 46 (21, 103) | 45 (22, 88) | 48 (22, 93) | 48 (23, 78) | 46 (22, 84) | 2 (–2 to 5) | 0.372 |
| 81–100 milli-g* | 26 (16, 99) | 27 (16, 103) | 26 (16, 88) | 28 (17, 93) | ||||
| >100 milli-g* | 42 (34, 99) | 46 (40, 103) | 43 (37, 88) | 51 (46, 93) | ||||
*1000 milli-g = 1 g = 9.81 m/s2, <40 milli-g is approximately equivalent to sedentary activities such as sitting, lying and ≥100 milli-g is approximately equivalent to activities undertaken at a moderate to vigorous intensity.
EQ-5D-3L = three-level version of five-dimension EuroQol scale; HADS = Hospital Anxiety and Depression Scale; ISWT = incremental shuttle walk test; miili-g = milli-gravity unit; MLHFQ = Minnesota Living with Heart Failure Questionnaire; REACH-HF = Rehabilitation EnAblement in CHronic Heart Failure.